Agios presents Phase 3 sickle cell disease trial results at EHA conference

June 13, 2026 9:00 AM

Agios Pharmaceuticals Inc. (NASDAQ: AGIO) presented detailed results from its RISE UP Phase 3 trial of mitapivat for sickle cell ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found